Evome Medical Technologies Inc.
LNDZF · OTC
12/31/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | 242% | 54,686.9% | -109.5% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 36% | 32.6% | 36,914.6% | -5.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16.6% | -17.7% | 4,285.3% | -464.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24.9% | -23.9% | 7,951.3% | -664.9% |
| EPS Diluted | -0.16 | -0.1 | -0.061 | -0.069 |
| % Growth | -60.3% | -63.7% | 11.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |